| scholarly article | Q13442814 |
| P50 | author | Karen L Kotloff | Q63214788 |
| Ethel D Weld | Q83195813 | ||
| P2093 | author name string | M M Levine | |
| M F Pasetti | |||
| W L Picking | |||
| M B Sztein | |||
| J K Simon | |||
| M Maciel | |||
| R Wahid | |||
| P2860 | cites work | Rapid cloning of high-affinity human monoclonal antibodies against influenza virus | Q24644672 |
| Mortality due to shigellosis: community and hospital data | Q33579264 | ||
| Characterization of B-cell epitopes on IpaB, an invasion-associated antigen of Shigella flexneri: identification of an immunodominant domain recognized during natural infection | Q33608118 | ||
| Global burden of Shigella infections: implications for vaccine development and implementation of control strategies | Q33749510 | ||
| Antigen dependent and independent mechanisms that sustain serum antibody levels | Q35134698 | ||
| Antimicrobial resistance among enteric pathogens | Q35797361 | ||
| Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors | Q36267084 | ||
| Conformational stability and differential structural analysis of LcrV, PcrV, BipD, and SipD from type III secretion systems | Q36388232 | ||
| B-cell memory: are subsets necessary? | Q36602594 | ||
| Induction of secretory immunity and memory at mucosal surfaces | Q36709727 | ||
| Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains | Q36720620 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Prospective study of systemic and mucosal immune responses in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides. | Q36966451 | ||
| Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei | Q36985066 | ||
| Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp | Q37010733 | ||
| Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates | Q37120727 | ||
| Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections | Q37167794 | ||
| Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh | Q37333494 | ||
| The mucosal immune system and its integration with the mammary glands | Q37682390 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins | Q40105951 | ||
| Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children | Q40163191 | ||
| Characterization of the interaction of single tryptophan containing mutants of IpaC from Shigella flexneri with phospholipid membranes | Q40332413 | ||
| Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2 | Q40687041 | ||
| Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers | Q40723111 | ||
| Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain | Q41480678 | ||
| IpaD localizes to the tip of the type III secretion system needle of Shigella flexneri | Q41856079 | ||
| Identification of the MxiH needle protein residues responsible for anchoring invasion plasmid antigen D to the type III secretion needle tip. | Q42518529 | ||
| Physical characterization of MxiH and PrgI, the needle component of the type III secretion apparatus from Shigella and Salmonella | Q43054516 | ||
| Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay | Q45412492 | ||
| Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination | Q47395264 | ||
| Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system | Q47756393 | ||
| Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage | Q48952832 | ||
| Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi | Q50146372 | ||
| CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. | Q50731424 | ||
| Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine. | Q51974027 | ||
| The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine. | Q51978164 | ||
| Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. | Q52016697 | ||
| Preparation and characterization of translocator/chaperone complexes and their component proteins from Shigella flexneri. | Q52579833 | ||
| A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. | Q54158784 | ||
| Live oral Shigella vaccine: vaccination schedule and the effect of booster dose. | Q54362925 | ||
| Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits | Q57128380 | ||
| Future needs and directions for Shigella vaccines | Q83284594 | ||
| P433 | issue | 2 | |
| P921 | main subject | immunization | Q1415366 |
| Shigella flexneri | Q1644417 | ||
| attenuated vaccine | Q1810913 | ||
| P304 | page(s) | 185-192 | |
| P577 | publication date | 2011-03-08 | |
| P1433 | published in | Clinical Immunology | Q15752921 |
| P1476 | title | Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates | |
| P478 | volume | 139 |
| Q41986831 | A randomized, placebo-controlled, double-blind Phase 2 trial comparing the reactogenicity and immunogenicity of a single ≥2x108 colony forming units [cfu] standard-dose versus a ≥2x109 cfu high-dose of CVD 103-HgR live attenuated oral cholera vaccin |
| Q34669980 | Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics |
| Q35805439 | Broadly protective Shigella vaccine based on type III secretion apparatus proteins |
| Q92230187 | Cell mediated immune responses elicited in volunteers following immunization with candidate live oral Salmonella enterica serovar Paratyphi A attenuated vaccine strain CVD 1902 |
| Q37067264 | Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea |
| Q37067290 | Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults |
| Q42421045 | Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level |
| Q34068059 | Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans |
| Q41426133 | Insights from natural infection-derived immunity to cholera instruct vaccine efforts |
| Q36017715 | Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans |
| Q91705205 | Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model |
| Q37105553 | Progress and pitfalls in Shigella vaccine research |
| Q38029250 | Recent progress in mucosal vaccine development: potential and limitations |
| Q38068954 | Recent progress towards development of a Shigella vaccine |
| Q92968346 | Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development |
| Q36981626 | Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malaria |
| Q91881906 | Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis |
| Q36920244 | Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. |
| Q34935297 | Shigella flexneri 3a outer membrane protein C epitope is recognized by human umbilical cord sera and associated with protective activity |
| Q56383780 | Shigellosis |
| Q34518265 | Status of vaccine research and development for Shigella |
| Q38010705 | The human intestinal IgA response; burning questions. |
Search more.